Top Markets
Coin of the day
Biostax Corp. Biostax Corp.

Biostax Corp.

BTAX
Classement en actions #41904
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition,... Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-duration toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$7.87K
Changement (1 jour)
0.00%
Changement (1 an)
-50.00%
Pays
US
Échange Biostax Corp. (BTAX)

Catégorie

Le prix BTAX avec la capitalisation boursière de B
Biostax Corp. Biostax Corp.
BTAX
$0.0001
Capitalisation boursière de Biostax Corp.(BTAX)
Capitalisation boursière: $7.87K
En August 2026, Biostax Corp. a une capitalisation boursière de $7.87K. Cela fait de Biostax Corp. la 41904th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Biostax Corp. du 2010 au 2026
BTAX par rapport au top 5 des plus populaires stocks
Prix pour BTAX L’actif B La capitalisation boursière de B Résultats
Biostax Corp. Biostax Corp.
$68,394.86 $7.87K
$5.383T +68,394,860,273.52%
Biostax Corp. Biostax Corp.
$56,198.59 $7.87K
$4.423T +56,198,592,248.34%
Biostax Corp. Biostax Corp.
$52,856.94 $7.87K
$4.160T +52,856,935,474.67%
Biostax Corp. Biostax Corp.
$46,542.00 $7.87K
$3.663T +46,542,000,115.98%
Biostax Corp. Biostax Corp.
$36,732.67 $7.87K
$2.891T +36,732,674,215.84%